China NT Pharma Group Overview

  • Year Founded
  • 1995

Year Founded

  • Status
  • Public

  • Employees
  • 32

Employees

  • Stock Symbol
  • 01011

Stock Symbol

  • Investments
  • 4

  • Share Price
  • $0.03
  • (As of Friday Closing)

China NT Pharma Group General Information

Description

China NT Pharma Group Co Ltd is a technology-based pharmaceutical company. It is engaged in research and development, production, and sale of private-label drugs, as well as the provision of pharmaceutical marketing and promotion services in China. It focused on the research, development, production, and sales of orthopedic, psychiatric, and oncology drugs. The Group's operations are regarded as having two operating and reportable segments, namely Agency Services and Healthcare Related Services. The company generates maximum of its revenue from Healthcare Related Services.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 28th Floor, Wellington Building
  • 198 Wellington Street, Sheung Wan
  • Hong Kong
  • Hong Kong
+852 2808
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Drug Discovery
Stock Exchange
HKG
Vertical(s)
Corporate Office
  • 28th Floor, Wellington Building
  • 198 Wellington Street, Sheung Wan
  • Hong Kong
  • Hong Kong
+852 2808

China NT Pharma Group Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

China NT Pharma Group Stock Performance

As of 20-Nov-2026, China NT Pharma Group’s stock price is $0.03. Its current market cap is $57.3M with 1.8B shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.03 $0.03 $0.02 - $0.13 $57.3M 1.8B 485K

China NT Pharma Group Financials Summary

As of 30-Jun-2026, China NT Pharma Group has a trailing 12-month revenue of $5.12M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 79,982 114,942 57,732 134,885
Revenue 5,120 3,359 5,290 1,041
EBITDA 163 309 (2,967) 187
Net Income (3,940) (3,621) (7,436) (20,296)
Total Assets 94,616 49,645 45,763 46,430
Total Debt 49,305 45,264 51,500 48,662
Public Fundamental Data provided by Morningstar, Inc. disclaimer

China NT Pharma Group Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore China NT Pharma Group‘s full profile, request access.

Request a free trial

China NT Pharma Group Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

China NT Pharma Group Investments & Acquisitions (4)

China NT Pharma Group’s most recent deal was a Merger/Acquisition with Junbinxiongdi. The deal was made on 28-Aug-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Junbinxiongdi 28-Aug-2025 Merger/Acquisition Holding Companies
Kangyuan Medical 05-May-2025 Merger/Acquisition Diagnostic Equipment
Suzhou First Pharmaceutical 23-Feb-2012 Corporate Distributors (Healthcare)
Suzhou First Pharmaceutical Merger/Acquisition Distributors (Healthcare)
To view China NT Pharma Group’s complete investments and acquisitions history, request access »

China NT Pharma Group ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Distribution

Subindustry

Rank

Percentile

To view China NT Pharma Group’s complete esg history, request access »

China NT Pharma Group Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Kangyuan Medical Hangzhou, China 2011

China NT Pharma Group FAQs

  • When was China NT Pharma Group founded?

    China NT Pharma Group was founded in 1995.

  • Where is China NT Pharma Group headquartered?

    China NT Pharma Group is headquartered in Hong Kong, Hong Kong.

  • What is the size of China NT Pharma Group?

    China NT Pharma Group has 32 total employees.

  • What industry is China NT Pharma Group in?

    China NT Pharma Group’s primary industry is Pharmaceuticals.

  • Is China NT Pharma Group a private or public company?

    China NT Pharma Group is a Public company.

  • What is China NT Pharma Group’s stock symbol?

    The ticker symbol for China NT Pharma Group is 01011.

  • What is the current stock price of China NT Pharma Group?

    As of 20-Nov-2026 the stock price of China NT Pharma Group is $0.03.

  • What is the current market cap of China NT Pharma Group?

    The current market capitalization of China NT Pharma Group is $57.3M.

  • What is China NT Pharma Group’s current revenue?

    The trailing twelve month revenue for China NT Pharma Group is $5.12M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process